Company Quick10K Filing
Invesco CurrencyShares Australian Dollar Trust
10-Q 2020-09-30 Filed 2020-11-06
10-Q 2020-06-30 Filed 2020-08-07
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-10-31 Filed 2019-01-11
S-1 2018-10-15 Public Filing
10-Q 2018-07-31 Filed 2018-09-07
10-Q 2018-04-30 Filed 2018-06-11
10-Q 2018-01-31 Filed 2018-03-12
10-K 2017-10-31 Filed 2018-01-11
10-Q 2017-07-31 Filed 2017-09-11
10-Q 2017-04-30 Filed 2017-06-09
10-Q 2017-01-31 Filed 2017-03-13
10-K 2016-10-31 Filed 2017-01-12
10-Q 2016-07-31 Filed 2016-09-09
10-Q 2016-04-30 Filed 2016-06-09
10-Q 2016-01-31 Filed 2016-03-11
10-K 2015-10-31 Filed 2016-01-14
10-Q 2015-07-31 Filed 2015-09-09
10-Q 2015-04-30 Filed 2015-06-09
10-Q 2015-01-31 Filed 2015-03-12
10-K 2014-10-31 Filed 2015-01-14
10-Q 2014-07-31 Filed 2014-09-08
10-Q 2014-04-30 Filed 2014-06-09
10-Q 2014-01-31 Filed 2014-03-12
10-K 2013-10-31 Filed 2013-12-20
10-Q 2013-07-31 Filed 2013-09-06
10-Q 2013-04-30 Filed 2013-06-07
10-Q 2013-01-31 Filed 2013-03-08
10-K 2012-10-31 Filed 2012-12-21
10-Q 2012-07-31 Filed 2012-09-10
10-Q 2012-04-30 Filed 2012-06-11
10-Q 2012-01-31 Filed 2012-03-12
10-K 2011-10-31 Filed 2011-12-23
10-Q 2011-07-31 Filed 2011-09-09
10-Q 2011-04-30 Filed 2011-06-09
10-Q 2011-01-31 Filed 2011-03-11
10-K 2010-10-31 Filed 2010-12-29
10-Q 2010-07-31 Filed 2010-09-09
10-Q 2010-04-30 Filed 2010-06-09
10-Q 2010-01-31 Filed 2010-03-12
10-K 2009-10-31 Filed 2010-01-14
8-K 2020-10-27
8-K 2020-10-20
8-K 2020-05-18
8-K 2020-03-27
8-K 2019-05-07
8-K 2019-01-09
8-K 2018-08-27
8-K 2018-06-04
8-K 2018-05-24
8-K 2018-04-19
8-K 2018-04-06

Invesco CurrencyShares Australian Dollar Trust Financials

FXA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-07-312011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-03-312019-06-302019-09-30
Cash867,749859,494797,079655,850589,253585,862610,197555,338376,910426,133318,437301,115283,547290,104218,025220,885183,583181,932245,000235,000235,000235,000235,000225,000220,000185,000165,000170,000175,000170,000150,000145,000145,000
Accounts Receivable
Inventory
PP&E
Assets101,83097,821
Accounts Payable
Long-Term Debt
Liabilities3632
Stockholders' Equity
Income Statement ($'000)2011-07-312011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-03-312019-06-302019-09-30
Revenue9,3039,1468,3307,2425,3014,7004,0313,6582,7372,1272,0071,7071,6791,4871,517946864724798693627459559526547504371425496444361285133
Cost of Revenue
Gross Profit
R&D
SG&A
Tax00000000000000
Net Income8,4508,3167,5056,5154,6834,0893,4263,0862,2781,7221,6251,3981,3811,2201,25574966754461451845227938435737833723929936732225417933
Cash Flow ($'000)2011-07-312011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-03-312019-06-302019-09-30
Cash Operating8,3117,9906,9185,0854,3663,5223,2202,4631,7391,6791,4521,4031,2431,22788365261655846235033537837037623034926821181
Cash Investing
Cash Financing12,467-69,359-132,414-75,3018417,404-55,347-117,64730,942-78,628-38,097-20,86322,137-42,876580-23,805-4,191-11,556-548-494-335-7,896-4,168-27,221-15,7173,624-10,966-3,501-78